Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 11 | 2024 | 462 | 4.020 |
Why?
|
Buprenorphine | 8 | 2024 | 184 | 3.920 |
Why?
|
Opiate Substitution Treatment | 8 | 2024 | 192 | 2.170 |
Why?
|
Eczema | 6 | 2023 | 9 | 1.310 |
Why?
|
Dermatitis, Atopic | 6 | 2023 | 20 | 1.300 |
Why?
|
Hypertension | 3 | 2023 | 598 | 1.240 |
Why?
|
Telemedicine | 2 | 2024 | 327 | 1.230 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2024 | 116 | 1.000 |
Why?
|
Narcotic Antagonists | 3 | 2023 | 114 | 0.950 |
Why?
|
Antihypertensive Agents | 2 | 2015 | 172 | 0.880 |
Why?
|
Asthma | 5 | 2023 | 416 | 0.800 |
Why?
|
Smoking Cessation | 7 | 2022 | 532 | 0.750 |
Why?
|
Drug Overdose | 1 | 2023 | 117 | 0.750 |
Why?
|
Mobile Applications | 1 | 2022 | 124 | 0.730 |
Why?
|
Health Promotion | 2 | 2015 | 489 | 0.660 |
Why?
|
Quality Indicators, Health Care | 2 | 2019 | 328 | 0.640 |
Why?
|
Prisons | 6 | 2022 | 114 | 0.610 |
Why?
|
Substance Abuse, Intravenous | 1 | 2018 | 74 | 0.580 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2018 | 103 | 0.580 |
Why?
|
Hepatitis C, Chronic | 1 | 2018 | 88 | 0.570 |
Why?
|
Dental Care | 1 | 2017 | 27 | 0.560 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 455 | 0.530 |
Why?
|
Humans | 36 | 2024 | 58820 | 0.530 |
Why?
|
Smoking Prevention | 4 | 2013 | 162 | 0.530 |
Why?
|
Oral Health | 1 | 2017 | 73 | 0.520 |
Why?
|
Medical Records | 1 | 2016 | 137 | 0.520 |
Why?
|
Antiviral Agents | 1 | 2018 | 313 | 0.500 |
Why?
|
Documentation | 1 | 2016 | 127 | 0.490 |
Why?
|
Prisoners | 5 | 2015 | 166 | 0.490 |
Why?
|
Healthcare Disparities | 2 | 2017 | 326 | 0.490 |
Why?
|
Fentanyl | 3 | 2024 | 69 | 0.460 |
Why?
|
Delivery of Health Care | 1 | 2017 | 417 | 0.420 |
Why?
|
Hypersensitivity | 2 | 2023 | 60 | 0.420 |
Why?
|
Lung Diseases | 1 | 2012 | 162 | 0.370 |
Why?
|
Smoking | 6 | 2022 | 829 | 0.370 |
Why?
|
Adult | 13 | 2024 | 15596 | 0.310 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 819 | 0.300 |
Why?
|
Male | 14 | 2024 | 27258 | 0.290 |
Why?
|
Tobacco Products | 2 | 2022 | 75 | 0.290 |
Why?
|
Longitudinal Studies | 3 | 2024 | 1198 | 0.280 |
Why?
|
Patient-Centered Care | 3 | 2018 | 245 | 0.280 |
Why?
|
Stroke | 1 | 2015 | 1135 | 0.270 |
Why?
|
Quality Assurance, Health Care | 2 | 2019 | 244 | 0.250 |
Why?
|
Washington | 1 | 2024 | 25 | 0.240 |
Why?
|
Oregon | 1 | 2024 | 19 | 0.240 |
Why?
|
Anesthetics, Dissociative | 1 | 2024 | 8 | 0.240 |
Why?
|
Primary Health Care | 3 | 2021 | 640 | 0.240 |
Why?
|
Smoke-Free Policy | 2 | 2015 | 9 | 0.240 |
Why?
|
Ketamine | 1 | 2024 | 33 | 0.230 |
Why?
|
Patient Preference | 2 | 2022 | 74 | 0.230 |
Why?
|
Janus Kinase Inhibitors | 1 | 2023 | 18 | 0.220 |
Why?
|
Dermatologic Agents | 1 | 2023 | 21 | 0.220 |
Why?
|
Sublingual Immunotherapy | 1 | 2022 | 1 | 0.210 |
Why?
|
Buprenorphine, Naloxone Drug Combination | 1 | 2022 | 26 | 0.210 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 701 | 0.200 |
Why?
|
Naloxone | 1 | 2022 | 54 | 0.200 |
Why?
|
Social Stigma | 1 | 2022 | 66 | 0.200 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 48 | 0.200 |
Why?
|
Smartphone | 1 | 2022 | 61 | 0.200 |
Why?
|
Female | 12 | 2024 | 30545 | 0.200 |
Why?
|
United States | 7 | 2023 | 7432 | 0.180 |
Why?
|
Middle Aged | 6 | 2024 | 16117 | 0.180 |
Why?
|
Young Adult | 3 | 2022 | 4270 | 0.180 |
Why?
|
Central Nervous System Agents | 1 | 2018 | 6 | 0.160 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2018 | 8 | 0.160 |
Why?
|
Induction Chemotherapy | 1 | 2018 | 33 | 0.160 |
Why?
|
Substance Abuse Detection | 1 | 2018 | 39 | 0.160 |
Why?
|
Cohort Studies | 1 | 2024 | 2428 | 0.150 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 487 | 0.150 |
Why?
|
Systems Integration | 1 | 2018 | 27 | 0.150 |
Why?
|
Benzodiazepines | 1 | 2018 | 97 | 0.150 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 432 | 0.140 |
Why?
|
Epidemics | 1 | 2017 | 22 | 0.140 |
Why?
|
Survival Rate | 1 | 2019 | 783 | 0.140 |
Why?
|
Motivation | 2 | 2022 | 266 | 0.140 |
Why?
|
Recurrence | 1 | 2018 | 575 | 0.140 |
Why?
|
Cotinine | 2 | 2013 | 18 | 0.140 |
Why?
|
Patient Compliance | 1 | 2019 | 370 | 0.140 |
Why?
|
Physician-Patient Relations | 2 | 2018 | 381 | 0.140 |
Why?
|
Medical History Taking | 1 | 2016 | 57 | 0.130 |
Why?
|
Counseling | 1 | 2018 | 349 | 0.130 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2017 | 114 | 0.130 |
Why?
|
Workload | 1 | 2016 | 118 | 0.130 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 95 | 0.130 |
Why?
|
Homicide | 1 | 2015 | 25 | 0.120 |
Why?
|
Poverty | 1 | 2017 | 286 | 0.120 |
Why?
|
Blood Pressure Determination | 1 | 2014 | 42 | 0.120 |
Why?
|
Physicians, Primary Care | 1 | 2015 | 71 | 0.120 |
Why?
|
Burnout, Professional | 1 | 2016 | 118 | 0.110 |
Why?
|
Reference Values | 1 | 2014 | 322 | 0.110 |
Why?
|
Network Meta-Analysis | 2 | 2023 | 15 | 0.110 |
Why?
|
Family Health | 1 | 2014 | 68 | 0.110 |
Why?
|
Violence | 1 | 2015 | 148 | 0.110 |
Why?
|
Personal Autonomy | 1 | 2013 | 66 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 662 | 0.110 |
Why?
|
Mass Screening | 1 | 2018 | 635 | 0.110 |
Why?
|
Motivational Interviewing | 1 | 2013 | 41 | 0.100 |
Why?
|
Pruritus | 2 | 2023 | 29 | 0.100 |
Why?
|
Health Services Accessibility | 1 | 2017 | 539 | 0.100 |
Why?
|
Quality of Life | 3 | 2023 | 1102 | 0.100 |
Why?
|
Blood Pressure | 1 | 2014 | 518 | 0.100 |
Why?
|
Emergencies | 1 | 2012 | 113 | 0.090 |
Why?
|
Skin Diseases | 1 | 2012 | 73 | 0.090 |
Why?
|
Health Status | 1 | 2014 | 448 | 0.090 |
Why?
|
Surveys and Questionnaires | 3 | 2014 | 2560 | 0.090 |
Why?
|
Family Practice | 1 | 2012 | 202 | 0.090 |
Why?
|
Aged | 3 | 2022 | 13210 | 0.090 |
Why?
|
Severity of Illness Index | 1 | 2014 | 1437 | 0.080 |
Why?
|
Adolescent | 2 | 2023 | 5862 | 0.080 |
Why?
|
Hospitals, University | 1 | 2009 | 51 | 0.080 |
Why?
|
Hospitals, Urban | 1 | 2009 | 43 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 737 | 0.080 |
Why?
|
Risk Assessment | 1 | 2014 | 1893 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 1010 | 0.070 |
Why?
|
Algorithms | 1 | 2012 | 981 | 0.070 |
Why?
|
Communication | 2 | 2018 | 531 | 0.060 |
Why?
|
Prospective Studies | 1 | 2012 | 3071 | 0.060 |
Why?
|
Patient Discharge | 1 | 2009 | 477 | 0.060 |
Why?
|
Administration, Sublingual | 1 | 2024 | 3 | 0.060 |
Why?
|
Patient Care Team | 2 | 2009 | 315 | 0.060 |
Why?
|
Tacrolimus | 1 | 2023 | 39 | 0.060 |
Why?
|
Child | 2 | 2023 | 4238 | 0.060 |
Why?
|
Methadone | 1 | 2024 | 126 | 0.050 |
Why?
|
Dermatophagoides pteronyssinus | 1 | 2022 | 2 | 0.050 |
Why?
|
Pyroglyphidae | 1 | 2022 | 3 | 0.050 |
Why?
|
Desensitization, Immunologic | 1 | 2022 | 9 | 0.050 |
Why?
|
Allergens | 1 | 2022 | 43 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 151 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2022 | 108 | 0.050 |
Why?
|
Immunoglobulin E | 1 | 2022 | 84 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 291 | 0.050 |
Why?
|
Odds Ratio | 2 | 2014 | 769 | 0.050 |
Why?
|
Nephrology | 1 | 2001 | 14 | 0.050 |
Why?
|
Endocrinology | 1 | 2001 | 21 | 0.050 |
Why?
|
Group Processes | 1 | 2001 | 40 | 0.050 |
Why?
|
Pilot Projects | 1 | 2024 | 909 | 0.050 |
Why?
|
Caregivers | 1 | 2023 | 214 | 0.040 |
Why?
|
Interprofessional Relations | 1 | 2001 | 130 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2001 | 145 | 0.040 |
Why?
|
Rural Population | 1 | 2021 | 188 | 0.040 |
Why?
|
Program Evaluation | 2 | 2017 | 478 | 0.040 |
Why?
|
Students, Medical | 1 | 2001 | 234 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2018 | 98 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 711 | 0.040 |
Why?
|
Diet | 1 | 2022 | 631 | 0.040 |
Why?
|
Infant | 1 | 2022 | 1507 | 0.040 |
Why?
|
Missouri | 1 | 2017 | 12 | 0.040 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 168 | 0.040 |
Why?
|
Health Policy | 1 | 2018 | 181 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2017 | 216 | 0.030 |
Why?
|
Self Care | 1 | 2017 | 211 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2015 | 81 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2015 | 20 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2018 | 405 | 0.030 |
Why?
|
Rhode Island | 1 | 2015 | 96 | 0.030 |
Why?
|
Dyspnea | 1 | 2015 | 107 | 0.030 |
Why?
|
Fatigue | 1 | 2015 | 103 | 0.030 |
Why?
|
Chest Pain | 1 | 2015 | 85 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2023 | 5096 | 0.030 |
Why?
|
New England | 1 | 2013 | 267 | 0.030 |
Why?
|
Cough | 1 | 2015 | 181 | 0.030 |
Why?
|
Intention | 1 | 2013 | 65 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2013 | 151 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2015 | 413 | 0.030 |
Why?
|
Dermatitis, Exfoliative | 1 | 2012 | 3 | 0.030 |
Why?
|
Purpura | 1 | 2012 | 3 | 0.030 |
Why?
|
Fasciitis, Necrotizing | 1 | 2012 | 4 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2012 | 11 | 0.020 |
Why?
|
Blister | 1 | 2012 | 17 | 0.020 |
Why?
|
Physical Examination | 1 | 2012 | 103 | 0.020 |
Why?
|
Psoriasis | 1 | 2012 | 51 | 0.020 |
Why?
|
Soft Tissue Infections | 1 | 2012 | 42 | 0.020 |
Why?
|
Social Support | 1 | 2013 | 356 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2013 | 925 | 0.020 |
Why?
|
Chronic Disease | 1 | 2014 | 727 | 0.020 |
Why?
|
Logistic Models | 1 | 2013 | 1245 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 893 | 0.020 |
Why?
|
Cost Savings | 1 | 2009 | 53 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 1220 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2012 | 249 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2014 | 2316 | 0.020 |
Why?
|
Biomarkers | 1 | 2013 | 1199 | 0.020 |
Why?
|
Boston | 1 | 2009 | 325 | 0.020 |
Why?
|
Time Factors | 1 | 2013 | 3544 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2009 | 444 | 0.020 |
Why?
|
Animals | 1 | 2022 | 19483 | 0.010 |
Why?
|
Hospitalization | 1 | 2009 | 1270 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2001 | 554 | 0.010 |
Why?
|